glp 1 safety long term glp-1 long-term use The Trap: Your Jumpstart Might Be a Forever Commitment Your GLP-1 journey is unique, – Three major reviews commissioned by

Back Braun, K, von Voss, P, Gotfredsen, CF, et al (1 Jan 2007) 'Liraglutide, a long-acting glucagon-like peptide-1 analog, reduces body weight and food intake in obese candy-fed rats, whereas a dipeptidyl peptidase-iv inhibitor, vildagliptin, does not', Diabetes , 56/1, 815

SGLT-2 inhibitors have a well-established association with genital mycotic infections, while the evidence for increased UTI risk is mixed

Preising J, Philippe D, Gleinser M, Wei H, Blum S, Eikmanns BJ et al (2010) Selection of bifidobacteria based on adhesion and anti-inflammatory capacity in vitro for amelioration of murine colitis

Regular monitoring and adjustment of the dosage are essential to prevent deficiency and maintain optimal health